Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (261-270 of 386) with videos related to

Pageof 39
Sort By:
Acta Neuropathologica|July 29, 2021
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'Rohit Gupta, Calixto-Hope G Lucas, Jasper Wu, et al.
Neuroimage. Clinical|August 25, 2022
Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-<sup>13</sup>C]pyruvate MRI data from patients with gliomaSana Vaziri, Adam W Autry, Marisa Lafontaine, et al.
Neuroimage|August 27, 2023
Hyperpolarized [2-<sup>13</sup>C]pyruvate MR molecular imaging with whole brain coverageBrian T Chung, Yaewon Kim, Jeremy W Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Oncology Nursing Forum|September 7, 2023
Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 PandemicJi Hun Kwak, Lynda A Mackin, Astrid Block, et al.
Neuro-Oncology|April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committeeKatherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Cancers|January 23, 2024
Advanced Hyperpolarized <sup>13</sup>C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI ApproachAdam W Autry, Sana Vaziri, Jeremy W Gordon, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Pageof 39

Showing results (261-270 of 386) with videos related to

Sort By:
Pageof 39
Acta Neuropathologica|July 29, 2021
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'Rohit Gupta, Calixto-Hope G Lucas, Jasper Wu, et al.
Neuroimage. Clinical|August 25, 2022
Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-<sup>13</sup>C]pyruvate MRI data from patients with gliomaSana Vaziri, Adam W Autry, Marisa Lafontaine, et al.
Neuroimage|August 27, 2023
Hyperpolarized [2-<sup>13</sup>C]pyruvate MR molecular imaging with whole brain coverageBrian T Chung, Yaewon Kim, Jeremy W Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.
Oncology Nursing Forum|September 7, 2023
Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 PandemicJi Hun Kwak, Lynda A Mackin, Astrid Block, et al.
Neuro-Oncology|April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committeeKatherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
Cancers|January 23, 2024
Advanced Hyperpolarized <sup>13</sup>C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI ApproachAdam W Autry, Sana Vaziri, Jeremy W Gordon, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Pageof 39